Compared with the control group, the ALS patients had significantly higher serum values for amylin, GIP, glucagon, insulin, and PP and significantly lower serum values for C-peptide, ghrelin, and leptin. The gene discussed is INS; the disease is amyotrophic lateral sclerosis.